Identification Of Novel Common Genetic Risk Factors For Endometriosis
Funder
National Health and Medical Research Council
Funding Amount
$593,783.00
Summary
Multiple genetic factors underlie susceptibility to endometriosis—a common gynaecological disease associated with severe pelvic pain and sub-fertility. Through the identification of novel genetic risk factors and pathway-based analyses, this project will increase our understanding of the underlying genetic architecture and complex molecular pathways of endometriosis and lead to the development of diagnostic tests and rational treatment strategies.
Life-saving chemo/radio-therapy commonly renders women and girls who survivor cancer infertile or sterile. We have discovered a new means of preserving the fertility of female mice exposed to chemo/radio therapy. In this project we will apply these advances to human ovarian tissue/eggs for the first time. We have access to these rare tissues for research purposes. This project will develop new approaches to fertility preservation for cancer survivors.
Leucine-rich Guanylate Kinase Is A Regulator Of Sperm Tail Development And Motile Cilia Function
Funder
National Health and Medical Research Council
Funding Amount
$540,191.00
Summary
In this grant we will define the function of an uncharacterized protein, LRGUK, in fertility and hydrocephalus (water on the brain). LRGUK has a critical role in sperm development. We will define the cell biology and biochemistry of LRGUK function, we will assess the incidence of LRGUK mutations in human fertility and explore LRGUK function in the brain. Data obtained will have relevance to the 1 in 20 young men who suffer from infertility and the 3 in 1000 children who develop hydrocephalus.
Medically Assisted Fertility Treatment And Infant Outcomes: The Role Of IVF (in Vitro Fertilisation), Ovulation Induction And Subfertility
Funder
National Health and Medical Research Council
Funding Amount
$463,001.00
Summary
Medically assisted fertility treatment such as IVF and fertility medications account for the birth of at least one in 25 children born in Australia. While the health outcomes of these children are reassuring there is a lack of conclusive findings on the clinical role of IVF and non-IVF treatments and on their safety, particularly the newer forms of IVF. This research will fill this evidence gap, informing patients and clinicians on the safety and effectiveness of fertility treatments.
Therapeutic Potential Of Transforming Growth Factor-beta Proteins For The Diagnosis And Treatment Of Female Infertility
Funder
National Health and Medical Research Council
Funding Amount
$942,961.00
Summary
We discovered and manufactured a growth factor produced uniquely by the egg. We named this growth factor cumulin. It is a powerful regulator of ovarian function and egg quality. This project will study the basic mechanisms of how cumulin works in the ovary. We will then develop an assay to measure it as a biomarker of human egg quality and quantity. New approaches in fertility preservation for cancer survivors will be developed using cumulin.
The Long-term Consequences Of Assisted Reproduction On The Growth, Metabolic, Respiratory, Psychological, Immunological And Reproductive Development Of The Offspring.
Funder
National Health and Medical Research Council
Funding Amount
$1,552,096.00
Summary
1 in 25 children are born from IVF treatment - incredibly- to our shame; no data exists as to the long-term health of these children. Presented is a unique opportunity, which would be exceedingly difficult to replicate elsewhere in the world, to determine the long-term consequences of IVF upon the development of the offspring, by comparing their growth, metabolic, respiratory, psychological, immunological and reproductive development to a representative sample of WA children- the Raine cohort.
Metabolic And Molecular Basis Of Embryo Signalling
Funder
National Health and Medical Research Council
Funding Amount
$409,836.00
Summary
Cells in the body are powered by mitochondria that essentially generate the energy required for development. This grant will determine how the environment affects the mitochondria in the developing embryo and determine the impacts to the embryo and pregnancy if a mitochondria is partially shut down.
Activin And Its Binding Protein, Follistatin Regulate Functions Of The Epididymis And Vas Deferens
Funder
National Health and Medical Research Council
Funding Amount
$612,736.00
Summary
Male reproductive disease is a serious health issue for many men and their partners. Worldwide, malformations of the male reproductive organs are increasing, infections and chronic inflammation of the genitourinary tract beset sexually active men and aging men, and infertility afflicts one in seven couples desiring children. The causes underlying these conditions are not well-understood. These studies are intended to identify new approaches for preventing and treating these conditions.
Clinical Review Of A Cohort Aged 22-33 Years Conceived Using Assisted Reproductive Technologies
Funder
National Health and Medical Research Council
Funding Amount
$946,454.00
Summary
In a recent study, using telephone-interviews, we compared the health and wellbeing of 547 singleton young adults born following assisted reproductive technologies (ART), with 549 matched controls. Reviewing their health when they are 22-33 years is possible because of their ongoing interest. We have a protocol in place to measure their cardiac and respiratory function and other aspects of growth and development. Our findings will fill a major knowledge gap about the longer term safety of ART.
Investigating Pathways Of Mitochondrial Quality Control In Diabetic Kidney Disease
Funder
National Health and Medical Research Council
Funding Amount
$944,518.00
Summary
The mitochondria, the “power plants” of the cell, are damaged and accumulate in the kidney in diabetes. The objective of this study is to investigate exactly how these dysfunctional mitochondria accumulate in the diabetic kidney. The ultimate aim of this study is to establish if mitochondrial health can be restored using new medicines that directly target mitochondria, which will then improve kidney function, leading to new therapies for people with diabetes.